Introduction norepinephrine

Introduction of chlorine or bromine into the 3- and/or 4- positions of the side chain yields more potent compounds in terms of hypotension in rats and dopamine p- hydroxylase inhibition (31. 32). The analog YP-279 (XXXV) is also hypotensive in rats but is said not to affect brain norepinephrine biosynthesis unlike fusaric acid or dibromofusaric acid (33-35). Fusaric acid amide (bupicomide, Sch 10595, XXXVI) is clinically effective at 300 to 1800 mg per day and is said to have hemodynamic effects similar to hydralazine (36. 37). The amide is... 

If we dehne a mood stabilizer as a medication that is both an effective anti-manic and antidepressant, then lithium arguably remains to this day the prototypical mood stabilizer. Lithium not only reduces the symptoms of acute BPAD, it also prevents the recurrence of additional mood episodes. Despite the fact that lithium has revolutionized the treatment of BPAD and remains nearly 50 years after its introduction as the single best treatment for many patients with BPAD, there is still no consensus as to how it works. Lithium exerts effects on several neurotransmitter systems (e.g., serotonin, dopamine, norepinephrine, acetylcholine), on second messenger systems inside the nerve cell, and on nerve cell gene expression. Yet, precisely how these varied effects produce lithium s therapeutic benefit remains unclear. 

Norepinephrine is the primary neurotransmitter produced and released by adrenergic neurons, and in literature it is also described as and called (-) noradrenaline or levarterenol. This vasopressor catecholamine reduces both the resistance and capacity of blood vessels by stimulating a-adrenoreceptors and having a direct cardiostimulatory effect, which is accomplished by activation of )3i-adrenoreceptors. Norepinephrine exhibits significantly less activity than epinephrine as a drug for widening blood vessels through the activation of jSj-adrenoreceptors. Elevation of both stylistic and diastolic blood pressure is a typical reaction to intravenous introduction of norepinephrine. 

As discussed in Chapter 6 Introduction to Autonomic Pharmacology, dopa is the precursor of dopamine and norepinephrine. Its structure is shown in Figure 28-2. Levodopa is the levorotatory stereoisomer of dopa. 

The SAR for norepinephrine uptake inhibition by amphetamine analogs is similar to that for inhibition of 5-HT reuptake. The protypical unsubstituted derivative, 2-phenethyl-amine, is a weak uptake inhibitor in isolated rat heart membranes (IDgo = 1.1 jM) (143). Introduction of a methyl group at the Cl position adjacent to the amino group results in a 10-fold increase in potency (i.e., dexamphetamine, (8), 1D = 0.18 pAO (143). Sibutra-mine, a tertiary amine, shows moderate NE uptake activity iK = 350 nAO, but its des-methyl and di-desmethyl metabolites, (JD-BTS 54 354 (44) and (R)-BTS 54 505 (46), exhibit potent activity values <20 nM) (see Table 15.10) (71). 

Fig. 12.1. Schematic representation of autonomic and somatic motor nerves. The sites of action of acetyichoiine (ACh), norepinephrine (NE), epinephrine (Epi), and dopamine (D) are indicated. Choiinergic receptors are designated as nicotinic (N) or muscarinic (M). (From Katzung BG. introduction to autonomic pharmacoiogy. in Katzung BG, ed. Basic and Ciinicai Pharmacoiogy, 9th Ed. New York McGraw-Hiii, 2004, pp. 75-93 with permission.)...

C3 does not affect secretion. The Clostridial neurotoxins, botulinum and tetanus toxin, both inhibit secretion. When we introduced tetanus toxin into PC 12 cells, secretion of norepinephrine was inhibited. There was reason to believe that C3 might be a fragment of Cl or D neurotoxins (see Introduction) or act in a similar way. Accordingly we asked if intracellular C3 inhibited secretion but we found that it did not. Cells which had taken up C3 and in which p21.bot had been substantially ADP-ribosylated still secreted norepinephrine normally (Fig. 5). 

In 2004,17 years after the introduction of Prozac , duloxetine hydrochloride (Cymbalta , Lilly) was approved in the U.S. Duloxetine has a chiral carbon and is the S enantiomer. Duloxetine is a dual reuptake inhibitor of serotonin and norepinephrine (SSNRI). It is effective against depression and... 

The enzymatic introduction of a functional group into a biologically important molecule is not only specific with regard to the location at which the reaction occurs in the molecule (see Chapter 4, Problem 50), but also usually specific in the stereochemistry obtained. The biosynthesis of epinephrine first requires that a hydroxy group be introduced specifically to produce (—(-norepinephrine from the achiral substrate dopamine. (The completion of the synthesis of epinephrine wdl be presented in Problem 71 of Chapter 9.) Only the (—) enantiomer is functional in the appropriate physiological manner, so the synthesis must be highly stereoselective. 

---